Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. futures edge lower ahead of data, earnings; Dow Jones down 0.06%

Published 04/23/2014, 06:40 AM
U.S. futures point to lower open, fresh earnings ahead

Investing.com - U.S. stock futures pointed to a slightly lower open on Wednesday, as investors remained cautious ahead of U.S. economic reports, as well as a fresh batch of first quarter earnings reports to be released later in the day.

Ahead of the open, the Dow 30 futures pointed to a 0.06% dip, S&P 500 futures signaled a 0.10% fall, while the Nasdaq 100 futures indicated a 0.16% loss.

Markets showed little reaction to data earlier showing that the preliminary reading of China’s HSBC manufacturing purchasing managers’ index came in at 48.3 this month, up slightly from a final reading of 48.0 in March, but still below the 50 line separating expansion from contraction.

Tech stocks were expected to be active, after data compiled by Bloomberg showed that Apple (NASDAQ:AAPL) revenue is projected to be flat this year for the first time in at least a decade, while profit is estimated to decline 5%, making it the sixth consecutive period with little to no gains.

Separately, Google (NASDAQ:GOOGL), down 0.08% in after-hour trade, said its stake in the outcome of a $2 billion trial over smartphones using its Android operating system was revealed by testimony that the company indemnified Samsung Electronics against some of Apple's patent claims.

In earnings news, biotech company Amgen Inc. (NASDAQ:AMGN) reported lower-than-expected sales of its top drug. Although executives assured investors the drop was seasonal and they were on target to meet their 2014 projections, the company's shares plummeted 2.36% in extended trading.

In the same sector, Gilead Sciences (NASDAQ:GILD) surged 3.77% pre-market after saying that Sovaldi, the company’s $1,000-a-pill medicine to treat hepatitis C, had sales of $2.27 billion in the first quarter, beating analysts' estimates by more than $1 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Other stocks likely to be in focus included Boeing (NYSE:BA), Procter & Gamble (NYSE:PG), Facebook (NASDAQ:FB), Dow Chemical (DCH1.DE), Omnicare (NYSE:OCR), F5 Networks (NASDAQ:FFIV), Zynga (NASDAQ:ZNGA), Texas Instruments (NASDAQ:TXN), Delta Airlines (NYSE:DAL) and Qualcomm (NASDAQ:QCOM), all scheduled to report quarterly results later in the day.

Across the Atlantic, European stock markets were lower. The DJ Euro Stoxx 50 fell 0.23%, France’s CAC 40 slid 0.35%, Germany's DAX slipped 0.23%, while Britain's FTSE 100 dipped 0.05%.

During the Asian trading session, Hong Kong's Hang Seng retreated 0.97%, while Japan’s Nikkei 225 rallied 1.09%.

Later in the day, the U.S. was to publish reports on new home sales and manufacturing activity.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.